Scarica l'app Stockscreener
2.74
2.14%
-0.06
Dopo l'orario di chiusura:
2.78
0.04
+1.46%
Precedente Chiudi:
$2.80
Aprire:
$2.82
Volume 24 ore:
2.15M
Relative Volume:
1.46
Capitalizzazione di mercato:
$1.02B
Reddito:
$146.59M
Utile/perdita netta:
$-2.93M
Rapporto P/E:
-112.30
EPS:
-0.0244
Flusso di cassa netto:
$-190.40K
1 W Prestazione:
-3.52%
1M Prestazione:
+4.18%
6M Prestazione:
+10.04%
1 anno Prestazione:
+43.46%
Intervallo 1D:
$2.74
$2.865
Intervallo di 1 settimana:
$2.65
$2.895
Portata 52W:
$1.84
$3.43
Cronos Group Inc Stock (CRON) Company Profile
Nome
Cronos Group Inc
Settore
Telefono
(416) 504-0004
Indirizzo
4491 CONCESSION RD 12, STAYNER, ON
Compare CRON vs TAK, HLN, TEVA, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CRON
Cronos Group Inc
|
2.74 | 1.05B | 146.59M | -2.93M | -190.40K | -0.0244 |
TAK
Takeda Pharmaceutical Co Adr
|
15.60 | 48.82B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.12 | 39.63B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.19 | 40.09B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
79.44 | 33.34B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
549.87 | 23.25B | 3.17B | 1.29B | 1.01B | 27.09 |
Cronos Group Inc Stock (CRON) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-27 | Iniziato | Canaccord Genuity | Buy |
| 2022-11-02 | Iniziato | Bernstein | Mkt Perform |
| 2022-07-28 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2022-05-11 | Aggiornamento | CIBC | Neutral → Sector Outperform |
| 2022-03-22 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2022-01-27 | Aggiornamento | Jefferies | Underperform → Hold |
| 2021-11-18 | Ripresa | BofA Securities | Underperform |
| 2021-04-28 | Ripresa | BofA Securities | Underperform |
| 2021-02-22 | Downgrade | CIBC | Sector Outperform → Neutral |
| 2020-06-24 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-04-27 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-04-14 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-04-02 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2020-03-31 | Downgrade | Canaccord Genuity | Hold → Sell |
| 2020-03-04 | Aggiornamento | MKM Partners | Neutral → Buy |
| 2020-03-03 | Downgrade | Stifel | Buy → Hold |
| 2019-10-18 | Aggiornamento | Stifel | Hold → Buy |
| 2019-09-20 | Iniziato | MKM Partners | Neutral |
| 2019-09-05 | Aggiornamento | BMO Capital Markets | Underperform → Market Perform |
| 2019-08-13 | Iniziato | Piper Jaffray | Overweight |
| 2019-08-09 | Aggiornamento | Canaccord Genuity | Sell → Hold |
| 2019-06-28 | Iniziato | Consumer Edge Research | Equal Weight |
| 2019-06-06 | Iniziato | Stifel | Hold |
| 2019-06-05 | Aggiornamento | BofA/Merrill | Underperform → Buy |
| 2019-04-17 | Iniziato | BofA/Merrill | Underperform |
| 2019-03-27 | Downgrade | Canaccord Genuity | Hold → Sell |
| 2019-02-25 | Iniziato | Jefferies | Underperform |
| 2019-01-18 | Iniziato | CIBC | Sector Outperform |
Mostra tutto
Cronos Group Inc Borsa (CRON) Ultime notizie
Cronos Group sells entire stake in medical marijuana company - Digital Journal
Cronos Group Inc. stock falls Friday, still outperforms market - MarketWatch
Cronos Group Inc stock (CA22717L1013): cannabis share edges lower amid sector weakness - AD HOC NEWS
Cronos Group Inc. stock rises Thursday, outperforms market - MarketWatch
TSX Cannabis Stocks Watchlist: Names, Risks, and Signals to Follow Now - Kalkine Media
Cannabis Stocks to Watch as TSX Leadership Narrows - Kalkine Media
Cronos Group Inc. stock falls Tuesday, underperforms market - MarketWatch
Cronos Group Shares Surge 40 Percent as Q1 Earnings Beat Wall Street Estimates - asatunews.co.id
Canadian Penny Stocks Gaining Fresh Momentum This Month - Kalkine Media
What Companies Does Altria Own? - The Motley Fool
CRON Technical Analysis & Stock Price Forecast - Intellectia AI
CRON Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Cronos Group Inc (CRON) Stock Was Rising. Can the Rally Continue After Q1 Results? - Insider Monkey
CRON Q1 2026 Earnings: Positive EPS Surprise Despite Lack of Revenue DisclosureEarnings Beat Alert - The Legal Advocate
Cronos Quarterly Earnings Buoyed by Rise in Sales Volumes - 富途牛牛
CRON Q1 2026 Earnings: EPS Surprise Breaks Estimates Despite Flat RevenueFinancial Health Score - thelegaladvocate.com
Cannabis Giants Facing a Tough Reset Across Public Markets - Kalkine Media
Can These Cannabis Stocks Navigate Sector Challenges Ahead? - Kalkine Media
Looking Beyond Cultivation: Cannabis Names Shaping New Paths - Kalkine Media
CRON Technical Analysis | Trend, Signals & Chart Patterns | CRONOS GROUP INC (NASDAQ:CRON) - ChartMill
Cronos Group (CRON) Surges 4.4% as Cannabis Sector Momentum Gathers PaceVolatility Breakout Picks - thelegaladvocate.com
Cronos Group Inc stock (CA22717L1013): cannabis player trades steady on Nasdaq amid sector headwinds - AD HOC NEWS
(CRON) Strategic Investment Guide (CRON:CA) - Stock Traders Daily
Quad-Cities Investment Group, LLC's Cronos Group Inc(CRON) Holding History - GuruFocus
CRON.CA Stock Price, Quote & Chart | CRONOS GROUP INC (TSX:CRON) - ChartMill
Cronos Group Company Profile & Introduction - Moomoo
Canopy Growth Is Restating Two Years of Financials Before June 15 Earnings -- Here's What CGC Investors Need to Know Right Now - The Motley Fool
Can Cronos Group Keep This Cannabis Momentum Alive? - Kalkine Media
Does Stronger Q1 Profitability And Spinach Vape Gains Change The Bull Case For Cronos Group (TSX:CRON)? - simplywall.st
Cronos Group Inc. stock rises Wednesday, outperforms market - MarketWatch
Cronos Group (CRON) price target increased by 10.71% to 3.79 - MSN
Cannabis Stocks Draw Attention As Rescheduling Debate Gains Momentum - Kalkine Media
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
Cronos Expands Spinach STIX Pre Rolls And Chases Canadian Market Share - Yahoo Finance
Cronos Group stock (CA22717L1013): cannabis player shifts focus as Q1 loss widens - AD HOC NEWS
Cronos targets Canadelaar close in summer 2026 while renewing $50M buyback - MSN
Cronos Group (CRON) Q1 earnings meet estimates - MSN
Cronos Group Inc. stock falls Friday, underperforms market - MarketWatch
Is Cronos Group stock a buy? - Cantech Letter
Cronos: Strong Q1 Earnings Driven By International Cannabis Sales - Seeking Alpha
Cronos Group (CRON) officer exercises 10,597 RSUs, with 5,199 shares for tax - Stock Titan
Cronos Group (CRON) officer receives 10,367 shares as RSUs vest - Stock Titan
Cronos Group (CRON) officer exercises RSUs and withholds shares to cover taxes - Stock Titan
Cronos Group (CRON) officer settles RSUs and tax withholding shares - Stock Titan
Cronos Group Inc. stock falls Wednesday, underperforms market - MarketWatch
Short-Seller Left Didn’t Make ‘Sense,’ Cronos CEO Testifies - Bloomberg.com
Cronos: Excellent M&A And Favorable Valuation Make This A Buy (Upgrade) (NASDAQ:CRON) - Seeking Alpha
Cronos Group stock (CA22717L1013): Q1 revenue hits record $45.2M amid rescheduling boost - AD HOC NEWS
Short-Seller Left ‘Didn’t Make Much Sense,’ Cronos CEO Testifies - Bloomberg.com
Cronos Group (CRON) executive converts 3,118 RSUs into common shares, holding 211,555 shares - Stock Titan
Cronos Group (NASDAQ: CRON) officer converts RSUs into 20,470 common shares - Stock Titan
Cronos Group Inc Azioni (CRON) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cronos Group Inc Azioni (CRON) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Wagner Adam | See remarks |
May 12 '26 |
Option Exercise |
0.00 |
10,367 |
0 |
103,987 |
| Buggy Shannon | See Remarks |
May 12 '26 |
Option Exercise |
0.00 |
20,622 |
0 |
187,501 |
| Kenost Jared Matthew | See Remarks |
May 12 '26 |
Option Exercise |
0.00 |
9,412 |
0 |
46,675 |
| Weigensberg Arye | See Remarks |
May 10 '26 |
Option Exercise |
0.00 |
3,118 |
0 |
211,555 |
| Wagner Adam | See remarks |
May 10 '26 |
Option Exercise |
0.00 |
20,470 |
0 |
93,620 |
| Kenost Jared Matthew | See Remarks |
May 10 '26 |
Option Exercise |
0.00 |
12,649 |
0 |
39,141 |
| Shlimak Anna | See Remarks |
Mar 19 '26 |
Option Exercise |
0.00 |
28,429 |
0 |
368,362 |
| Doucet Terrence Gregory Joseph | See Remarks |
Mar 15 '26 |
Option Exercise |
0.00 |
23,897 |
0 |
117,466 |
| Weigensberg Arye | See Remarks |
Mar 15 '26 |
Option Exercise |
0.00 |
24,236 |
0 |
208,437 |
| GORENSTEIN MICHAEL RYAN | See remarks below |
Mar 15 '26 |
Option Exercise |
0.00 |
324,540 |
0 |
13,340,723 |
9.79%
0.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):